HSP90AB1 and Alzheimer disease: HSP90AB1 and PPP3R1 expression levels were significantly lower in AD patients than in non-AD controls, whereas the remaining 29 DEGs were significantly higher in AD patients (Figures 3F, G), suggesting that these immune microenvironment-related DEGs may be closely linked to AD progression.